Loading clinical trials...
Loading clinical trials...
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Kansas Medical Center
NCT06052475 · Pacing-Induced Cardiomyopathy, Heart Failure
NCT06675552 · Heart Disease, Heart Failure, and more
NCT05677100 · Heart Failure, Cardiorenal Syndrome, and more
NCT04405583 · Heart Failure
NCT07069738 · Heart Failure - NYHA II - IV
Scripps Health
La Jolla, California
Indiana University
Bloomington, Indiana
University of Kansas Medical Center
Kansas City, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions